Received: from PAZP264CA0250.FRAP264.PROD.OUTLOOK.COM (2603:10a6:102:239::9) by PR3PR02MB5980.eurprd02.prod.outlook.com (2603:10a6:102:6a::24) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.339.12; Mon, 24 Aug 2026 18:13:13 +0000 Received: from MI3PEPF00008493.eurprd03.prod.outlook.com (2603:10a6:102:239:cafe::14) by PAZP264CA0250.outlook.office365.com (2603:10a6:102:239::9) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.339.12 via Frontend Transport; Mon, 24 Aug 2026 18:13:13 +0000 Received: from mail1.rit.ee (213.184.53.4) by MI3PEPF00008493.mail.protection.outlook.com (10.167.240.154) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.360.3 via Frontend Transport; Mon, 24 Aug 2026 18:13:12 +0000 Received: from PR3PR02MB5980.eurprd02.prod.outlook.com (2603:10a6:102:6a::24) by DB9PR02MB7817.eurprd02.prod.outlook.com with HTTPS; Mon, 24 Aug 2026 18:13:17 +0000 Received: by mail-lf1-f42.google.com with SMTP id 2adb3069b0e04-5b29599b81cso4703453e87.1 for ; Mon, 24 Aug 2026 11:13:10 -0700 (PDT) Received: from smtpclient.apple (0f21-38dd-b166-3165-9880-81b6-07d0-2001.dyn.estpak.ee. [2001:7d0:81b6:9880:3165:b166:38dd:f21]) by smtp.gmail.com with ESMTPSA id 2adb3069b0e04-5b48ce06985sm1948736e87.56.2026.08.24.11.13.08 for (version=TLS1_2 cipher=ECDHE-ECDSA-AES128-GCM-SHA256 bits=128/128); Mon, 24 Aug 2026 11:13:09 -0700 (PDT) From: "Pille Konno" To: "Info - SOM" References: <1664927800.1118.1787572533938.JavaMail.dhs29@dhs-app10.just.sise> In-Reply-To: <1664927800.1118.1787572533938.JavaMail.dhs29@dhs-app10.just.sise> Subject: =?utf-8?Q?Re:_Sotsiaalkaitseministri_m=C3=A4=C3=A4ru?= =?utf-8?Q?s_nr_74_eeln=C3=B5u_=28abivahendite_loe?= =?utf-8?Q?telu=29?= Date: Mon, 24 Aug 2026 21:12:58 +0300 Keywords: ly Message-ID: <9C8AE254-5E56-43F3-B4A3-4F2BA6CA5AA2@dermatology.ee> MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_0010_01DD346F.02748DB0" X-Mailer: Apple Mail (2.3826.700.81) Thread-Index: AQGdDQnHERby9xtx+sOOGAtX0eInOgLdY5OM Authentication-Results: spf=none (sender IP is 213.184.53.4) smtp.mailfrom=dermatology.ee; dkim=pass (signature was verified) header.d=dermatology-ee.20251104.gappssmtp.com;dmarc=none action=none header.from=dermatology.ee;compauth=pass reason=106 x-ms-traffictypediagnostic: MI3PEPF00008493:EE_|PR3PR02MB5980:EE_|DB9PR02MB7817:EE_ X-MS-Office365-Filtering-Correlation-Id: f8b42a0e-dcfa-4e85-a6f5-08df020b5c7c X-MS-Exchange-AtpMessageProperties: SA|SL X-MS-Exchange-Transport-CrossTenantHeadersStamped: PR3PR02MB5980 X-MS-Exchange-Organization-ExpirationStartTime: 24 Aug 2026 18:13:12.9468 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: f8b42a0e-dcfa-4e85-a6f5-08df020b5c7c X-EOPAttributedMessage: 0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Exchange-Organization-AuthSource: MI3PEPF00008493.eurprd03.prod.outlook.com X-MS-Exchange-Organization-SCL: -1 X-MS-PublicTrafficType: Email X-Microsoft-Antispam: BCL:0;ARA:13230040|82310400026|43022699015|56012099006|5063699009|10067099003|19002099009|8096899003|22082099003|16102099003|55112099003|11063799006|18002099003|13003099007; X-Forefront-Antispam-Report: CIP:213.184.53.4;CTRY:EE;LANG:et;SCL:-1;SRV:;IPV:CAL;SFV:NSPM;H:mail1.rit.ee;PTR:mail1.rit.ee;CAT:NONE;SFS:(13230040)(82310400026)(43022699015)(56012099006)(5063699009)(10067099003)(19002099009)(8096899003)(22082099003)(16102099003)(55112099003)(11063799006)(18002099003)(13003099007);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 24 Aug 2026 18:13:12.7831 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: f8b42a0e-dcfa-4e85-a6f5-08df020b5c7c X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-AuthSource: MI3PEPF00008493.eurprd03.prod.outlook.com X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-EndToEndLatency: 00:00:04.7302243 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0339.010 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(4710232)(4717077)(4999285)(920097)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?2IcM9dCzsv1ie8cmeNLXoudtaKSy2zJsSbfZLU2cg+WvZZsG2O9xDufE8kdD?= =?us-ascii?Q?wyzs0PmEt7820Q5zwyjzOd50j6bNIkwaets3fSy2RorgW9vOCePDtCLFLv2G?= =?us-ascii?Q?E/sV1Q0PYTGhEcfYnoqUqeaK3MtsuFOFzyDRdTM4+uJQ5wi/RvLXNuaylbBM?= =?us-ascii?Q?nKw2rj70vQITkP39yzU2N2g81PAIREncL2E5SlHCB0GinDlB/IcW6QnoZLWm?= =?us-ascii?Q?m28X31ZnmE2P+8dKVaTWu+OoXjozys4p3zKxC25sQ8q6GKcmxDmNykPlgDAW?= =?us-ascii?Q?cJqDYYKa7hnGF/H6CprjHBaKUjmG6umUQVP1fcXAgpDVODWeTyBJFW23XGhY?= =?us-ascii?Q?/1nJokbpIswX3gJLbccjzNkQe5VrNQoqI4ObWye84XyB3mJ2sMoa7T+7My1h?= =?us-ascii?Q?KOk6uCJa4mOnEfI6ITT1vyWQkMbZ7fXp+2nwZnMeEhvCflpfRCV20Km/+LSe?= =?us-ascii?Q?fzgacQSezNIbXnM5oSoo2RAIQT8d9dKvtDhX3OEO2RmGKXcfTCCVL94mzO1W?= =?us-ascii?Q?UbcaXFqXk4lblceTOCdaOZgZBjFrQ2kNMa171W5Kpbw+a/zxNMJnXkH+GRqM?= =?us-ascii?Q?cGCR+FTzU8IJgPzsRg/ePDf82i0bQ4U6KU+P5Vr+jrFETJoBQLWQl7o2moF/?= =?us-ascii?Q?MD+zzf5bfq0rceZFlzq1hWvDmlqmrQOddZuWfUm6VEUPkDNb2ZYzjyxhsW2+?= =?us-ascii?Q?IPkYLMCSZG5gq4qJ9xkZdagOE1mUVsERkOzIt/yEYT3NDFRRVge siA8vLsN+?= =?us-ascii?Q?dGXxwDkj+0VtJEVXJfs/nQ00oqpSyq9u6eV2EhgzGvS9uU3C4O6E7s1SWFnh?= =?us-ascii?Q?kgpn4GhrPrnPbKyqHWEpic8qyFy65uAGB5dZ3O1Fs2qhWfnuxnVxbZmZMyEL?= =?us-ascii?Q?rTVkmJaHROTQTVzPVNz5kqZUqWhor0OOEBWMWpvfN4VhnFBqcmv2JGQaJJhp?= =?us-ascii?Q?/WJYeO8SgMhgNmWSQtFtIHDY2AliHcmdnIBmrTF2e5jN7cA+GWZfMnYRRf8S?= =?us-ascii?Q?BhuRLaYt5bc8Eq1hogNoj6FM3ZASO8inl7nLKgjavEUXYcmBn2NgSu4bDJHD?= =?us-ascii?Q?kVTfCWsurbn1DB8EoJdsPriziOb+TonP3p51nreKnDWuz08Bm4j1u8ZORKRz?= =?us-ascii?Q?F0N3/Bu8dI/38y8vk9z7epcniEBxZPS33h4FQf4YGW58KuXWo3c4ZgXXA+Ss?= =?us-ascii?Q?8jprQesnTMtew/2pb2qjn2TqmKRrV0xbQCDKfXPnFAzwPfv7fdZukMCalHqD?= =?us-ascii?Q?kAv/Wbd0AEwyeD1tjcpBxGADC8NRAzkQDc1CqcwHEJZDrKF7luNj8Jn1mIF/?= =?us-ascii?Q?PF6Gd8enKCy8AzC8i/iK7PxsZJLtLUNMw6HOTAtey855yncY0LRfik5l57Gk?= =?us-ascii?Q?rFVUjU/DowuuB8qY9sWhfbAhUhgya+xAjnQQnQ+KeJFycO6542V40J6/o1/E?= =?us-ascii?Q?sZTskQ8pYlEfBYGfo80XH8032p9PRMdJ0wfHjdXJ34+aRgIPpaY8yqDwmzIZ?= =?us-ascii?Q?bjAKl6TVt19Cp5ELni3uzKTunWzLILbPpPPHp 9hVRauYwlFUJaOrrdVkSVkd?= =?us-ascii?Q?0xyZGjR5kE9AcKhIhMNOg3O9Di7/X7hSz+qVzv7ViYEFs5NXCKGOKN3gWEso?= =?us-ascii?Q?5+37/D4wbujdhHvVhIQ2/bFWrSD5pvjLpBxegfzbhytbFDMuPEEeb5kggFJu?= =?us-ascii?Q?4C0vWM6nLbr0DFEtt4wol9O9eE8DV/vCLrFIBCepx/KIVEhb5uoghsjTSiVh?= =?us-ascii?Q?myVjxkVthoku8h63h/CoUnl34jQBF69joRNAqkt2WeoFRmD5HeKKyeEXBz+L?= =?us-ascii?Q?Ds3vCrmk/5wuyAMDfTlvmCvx9lZQjQvgveIN1dsGF5x/X6fUCvyJWuk2dfOe?= =?us-ascii?Q?JbFiTvi4IHIVUHpgPFTOvMmQFUPFG0RiF3LbSfLTPv3t4YgVq4a4kdNPV1kd?= =?us-ascii?Q?/S+3Ok/378YE2G/a8tq3dejyejuP3yxu2zky1Y9tHQgTXNoZeG3xhxcs8VLY?= =?us-ascii?Q?qES1aHnsFh+sJUVChUgF9PChQFjG0yT2wl78TxS4VKenl0su/3a0yXqzGIGY?= =?us-ascii?Q?ogSvXddDifiwIah8asgceULpG7xaaoTkRrvn7Sl/V5GoZfn01LTqMWyPqfZx?= =?us-ascii?Q?Je2pPlzyn5aXRbfMrp9tGu0wgsLd/tv8rfRvRPPZXloXIy3QTRipdTvd9g42?= =?us-ascii?Q?7oQU9YH5Gmbegp2vhTbZTUeGRTbm8ZNNwIRcQ1Q4VMArQvxD4V3miE2aHook?= =?us-ascii?Q?mKiutjhuvuA4gaM9A7z+ZVYcZoRp3PKAtGkCyJEre3VySPMj42D3AoOLScHx?= =?us-ascii?Q?Co9tRBBhzktjArI9mUohEpe 5N4iBJa7tm4JzDhhHPwImLzTqJsIIsA53ZmdN?= =?us-ascii?Q?ai7WrN+rX2NZC/tTrtQ2SnlyUWCLK6Z29CBYTvArkakWTd4fnPiCUDxLtpM1?= =?us-ascii?Q?XWbEmGoto6dtAzpqtBzVbjtyX4hPUZle2kCpclPLRZ/7LAFapAfdiy1bGccb?= =?us-ascii?Q?QUvfYFiHexm7+2yAys0fUuBmLRUimu5yMlY8qfv6oQ75c0EFoK6oMHHH3Omr?= =?us-ascii?Q?JMAr5PFsAUIWSU7ofL1xhvlTGNLyv4uCjvoCNXA9Hg+aUlhgdbjBGBx5fA0y?= =?us-ascii?Q?o/VIq2mynw7Dc23EaerJUMYcc9/+pW/uFutUZ2CgmFpve9RzOmSQmaKJyfoj?= =?us-ascii?Q?NBUSsOJ6pQCgtrvwDFhzEhTZABQEyI+ngb33OGY1hMGmUSYjtN3Mpoj7cmdk?= =?us-ascii?Q?PD7IT6Q1C9LGTy+tVTGo7rer5VvTwere46ftYjEUwpj2emqQ7U05ipF0vvfP?= =?us-ascii?Q?eBc+ZdUMp6+28Q=3D=3D?= Content-Language: en-us received-spf: None (mail1.rit.ee: no sender authenticity information available from domain of postmaster@mail-lf1-f42.google.com) identity=helo; client-ip=209.85.167.42; receiver=mail1.rit.ee; envelope-from="pille@dermatology.ee"; x-sender="postmaster@mail-lf1-f42.google.com"; x-conformance=spf_only x-ms-exchange-organization-originalclientipaddress: 213.184.53.4 x-ms-exchange-organization-originalserveripaddress: 10.167.240.154 X-OlkEid: 0000000033F4068251E5764083FB7241D8AC8008070034AD76187591974DBF6C4F76951C873A0100020000000000EE036A86AA193F47AA713E32FE8F2E5700000000130D000056CFE2A0DF5CA14CA3EFD8A54F650D27 X-CSE-ConnectionGUID: qEgKmIe+Thi7g4P6fsjJSw== X-CSE-MsgGUID: tGqpctDcTjiZw8XQ3nYjBg== X-ThreatScanner-Verdict: Negative X-IPAS-Result: =?us-ascii?q?A0EeAwAwiYxqgSqnVdFXA4QWgQSBCoESBFSEWINPjieBK?= =?us-ascii?q?YMSkwl5h1oCDwEBAQEBAQsBMSAEAQEDAQOEfgKNbSAGOhMBAgEDAwIDAQEBA?= =?us-ascii?q?QEBAQEBAQELAQEBBAEBAQIBAQIEAwEBAQECEAEBIhkHDjuGTw2CWztxgSUBA?= =?us-ascii?q?QEBAQEBAQEBAQEBHQIfB2QBAQEBAgEjHQEBBzEECwkCDAwqAgIzAQUBHBmDA?= =?us-ascii?q?gGCIgEGJCejEZsjeoEygQGCDAEBBoEI2yuBaQkJAQyBN4Vxgm0BKoE1A4QGE?= =?us-ascii?q?IQCekKCDYE8G4JpPoRkJgaDDjqCMIImgQyBPpIXSApiECIDJjMsAVUTDQoLB?= =?us-ascii?q?wWBI0MDNRIqFSNLBS0dgSMhHRcXHlgbBgUSICpBQwEjAz6BGUECgXU/Ixk2f?= =?us-ascii?q?IEJXoErKWECEBdGLhWCBwKCWoEnXgIBSUMOB0ciCxgNSBEsNxQZQm4HjXtiH?= =?us-ascii?q?4QFgQYvpmiLfpUXhCiBZpl9hhcvgUuWCJMZkyuFXaRaAYQ9AgQBAQEDBwcRJ?= =?us-ascii?q?BKBSYF/MxoIMGUBgjwJNhEDGQ+SI2zLMHYCOwEBAgEEAgcBCwEBAwkBAYFoU?= =?us-ascii?q?I9kgUwBAQ?= X-Talos-CUID: 9a23:9T81R2OcuB4zOO5DQQRo10s1F4MZcnyCwyvofUGjC0RSV+jA X-Talos-MUID: =?us-ascii?q?9a23=3AyDZTPAy7AVwGAZZye43k1r7OcxuaqLiBEVgGjbk?= =?us-ascii?q?Nh8uFBzMgCw7GigW1aIByfw=3D=3D?= X-IronPort-Anti-Spam-Filtered: true X-IronPort-AV: E=Sophos;i="6.25,241,1779138000"; d="scan'208,217";a="78144739" X-Amp-Result: SKIPPED(no attachment in message) X-Amp-File-Uploaded: False X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=1e100.net; s=20251104; t=1787595190; x=1788199990; h=message-id:in-reply-to:to:references:date:subject:mime-version :content-type:from:x-gm-gg:x-gm-message-state:from:to:cc:subject :date:message-id:reply-to:content-type; bh=FNNy9RcRMutlrPsKtX6T7sF/WxkPfig+jguefqj2Zok=; b=f53HQ0LHUP9cgSXvibTUJN5PiezQGxYdDJ4Qbylcnn8lsJsgYHvXXm8yQ6molTV+Na nAD+IVYFF2qUyk88lPcI9gEpoH+01rQp2lW23HjG2TnQH2lfMAfW/9rG8QezrVcDz3dU fkg/EMGdQgBZ/47c5vWubAOyCUL/cAR6KcU06ScfZsv8geZk3iX2neRYN7Ch5UAWg409 IJFsy6UFa9UR3tmHrviesXfr6HzDfrRB5L2Df3YCsC19GwX9tbUXuszR+wEndvSbNctT RAhpMOEvGRtViBuHb7IQbAcBM1cJn8jqNS6RzoBjtjYyks135SBXwzfVVtaMLW0CnrlX B0EA== X-Gm-Message-State: AFuF++mRAvjYPfpDyfE8VdKP13Di9bny0DS5gR73OLkMyw/HhKYUp8QQ fyn82pms718+f80l93fPG8bKzZoQj6X5f+Qj7dvlUnDvCtwxHXiDkn9snQfCNK437Y8Nmc3gUbR wb7J8 X-Gm-Gg: AR+sD121UJg/RKBOl4tbjJFhoqDrCAv85pAFRiLD8HxxzWWQ0vHUb86gBrp7z2JaohZ Oxb3hzfbL6sElZJRms/nFmVR9MoNcI5jY43TNwwLkt4Vtve8gs+mdAbCE0HKT/ICk5dyAftCFzd SRZu+cvxIU7yNGLlVMkgi1ndhRT0LIuaM9Lz6NWAs6pkY8zKkrWqhxzAHErR5hDF/TewiaqEjQz 9/j4hbUFOfZTpzNaVXMNIHtOUJkRtVhkXg9uqR2W0yFZrX5ReWUVbVvNmM95hBvEsZ5R2uiyAnI bg/tIS77iMUX12U6kV7ARWxMpalgbzlqCHuqnXywoyjnJeMc8ltO1LzQAryEhrFpgOF1QG/lqgY t8MD0rmbGgBhriBijZVMGlQwVUhk1B0xeuXyvcvI5JioWP2pF0TuraTNGIq9P2/KwTiv0V+PqB/ dLhriMR8zhOEu1eCcSWzorYSqJ/gHKL3hNlkSIWMo1xwgaGSqzvGC5+pL1rH5dnFAdYbNHaDJJ9 hMdX2pgz/h74txEi9os2cH1s91B9jmG6j824RASeQS/CkI0bdUmRHRuZJaMKO45vT8wPn50igZs ADpS8doKLw== X-Received: by 2002:a05:6512:6187:b0:5ae:b01a:d213 with SMTP id 2adb3069b0e04-5b48b4835c7mr6879935e87.3.1787595189946; Mon, 24 Aug 2026 11:13:09 -0700 (PDT) X-EOPTenantAttributedMessage: 8fe098d2-428d-4bd4-9803-7195fe96f0e2:0 X-DisclaimerOO: 1 dkim-signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=dermatology-ee.20251104.gappssmtp.com; s=20251104; t=1787595190; x=1788199990; darn=sm.ee; h=message-id:in-reply-to:to:references:date:subject:mime-version :content-type:from:from:to:cc:subject:date:message-id:reply-to :content-type; bh=FNNy9RcRMutlrPsKtX6T7sF/WxkPfig+jguefqj2Zok=; b=tYSz6vRFX/ZNCAmJ6J0vDAxuIhs1+FOQd6KJdXPyclMP/sCTo/ub+UL/aqVycsHuce t5qixRMAAb1saBF0Iio1BP1tVwEoj0SD1dBGbY42+tYi+ssLLJguqqI15NhktiqW12L2 mKU2CoFDejy1QcvEBfqu7DDEl4ZlfV7X6iJucFos0YEFwSU4e9S8elc9uh+Mk7Ptb0Xd CZeecupdtv5d+F+Vusxs9AgxpN17rxwnFpOeFZ02DwkRdYNZAGVEUvwmfWYs/oMyxWGw +2IiVeYnH0JvLjjXzjtyqYVGjRAHq+VFRPgZGaVo1gmGu6JJz/0M/7OukoeAg5HWMNZw At/A== X-Ironport-Dmarc-Check-Result: validskip This is a multipart message in MIME format. ------=_NextPart_000_0010_01DD346F.02748DB0 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tervist, Tunnen, et ei ole minu pädevuses antud hinnakalkulatsioonide õigsust hinnata. Küll tekkis küsimus lik 6: ISO-kood 12.39.00.04 veterinaarkulud ISO-kood 12.39.00.06 õppepäev ISO-kood 12.39.00.07 lemmikloomakindlustus Austusega, Dr.Pille Konno Dermatoveneroloog On 24. Aug 2026, at 14:55, sm.dhs@sm.ee wrote: Tere! Teile on saadetud Sotsiaalministeeriumi dokumendihaldussüsteemi Delta kaudu eelnõu arvamuse avaldamiseks. Palume teie arvamusi arvamust hiljemalt 07.09.2026 e-posti aadressile info@sm.ee Pealkiri: Sotsiaalkaitseministri määrus nr 74 eelnõu (abivahendite loetelu) Registreerimise kuupäev: 24.08.2026 Registreerimise number: 1.2-2/72-1 Lugupidamisega Sotsiaalministeerium Suur-Ameerika 1, 10122 Tallinn Tel. (372) 626 9301, faks (372) 626 9209 e-post: info@sm.ee www.sm.ee <1.2-272-1 24.08.2026 Õigusakti eelnõu.asice> ------=_NextPart_000_0010_01DD346F.02748DB0 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable

T=C3=A4helepanu! Tegemist on v=C3=A4lisv=C3=B5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte = avada.
Tervist,

Tunnen, et ei ole minu p=C3=A4devuses antud hinnakalkulatsioonide = =C3=B5igsust hinnata.
K=C3=BCll tekkis k=C3=BCsimus lik 6: 
ISO-kood 12.39.00.04 = veterinaarkulud 

ISO-kood 12.39.00.06 = =C3=B5ppep=C3=A4ev 

ISO-kood 12.39.00.07 lemmikloomakindlustus

Austusega,
Dr.Pille Konno
Dermatoveneroloog
On 24. Aug 2026, at 14:55, sm.dhs@sm.ee wrote:

Tere!


Teile on saadetud Sotsiaalministeeriumi dokumendihalduss=C3=BCsteemi = Delta kaudu eeln=C3=B5u arvamuse avaldamiseks.

Palume teie arvamusi arvamust hiljemalt 07.09.2026 e-posti = aadressile info@sm.ee


Pealkiri: Sotsiaalkaitseministri m=C3=A4=C3=A4rus nr 74 eeln=C3=B5u = (abivahendite loetelu)

Registreerimise kuup=C3=A4ev: 24.08.2026

Registreerimise number: 1.2-2/72-1


Lugupidamisega


Sotsiaalministeerium

Suur-Ameerika 1, 10122 Tallinn
Tel. (372) 626 9301, faks (372) 626 9209
e-post: info@sm.ee
www.sm.ee

 
<1.2-272-1 = 24.08.2026 =C3=95igusakti eeln=C3=B5u.asice>

------=_NextPart_000_0010_01DD346F.02748DB0--